Several other pathways are also implicated; a recent animal study has demonstrated that the presence of MI-induced heart failure promoted mammary tumor cell growth through the NGF-TRKA pathways, suggesting that the inhibition of TRKA signalling pathways may be a potential therapeutic target for patients with breast cancer after MI (99). Here, NTRK1 is linked to heart failure.